These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 22607563

  • 1. Intermittent granulocyte and monocyte apheresis versus mercaptopurine for maintaining remission of ulcerative colitis: a pilot study.
    Sakuraba A, Sato T, Morohoshi Y, Matsuoka K, Okamoto S, Inoue N, Takaishi H, Ogata H, Iwao Y, Hibi T.
    Ther Apher Dial; 2012 Jun; 16(3):213-8. PubMed ID: 22607563
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J, Vilar P, Prieto G, García Novo MD, Ribes C, Varea V.
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [Abstract] [Full Text] [Related]

  • 3. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
    Yoshino T, Nakase H, Matsuura M, Matsumura K, Honzawa Y, Fukuchi T, Watanabe K, Murano M, Tsujikawa T, Fukunaga K, Matsumoto T, Chiba T.
    Digestion; 2011 Apr; 84(1):3-9. PubMed ID: 21311190
    [Abstract] [Full Text] [Related]

  • 4. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.
    Sakuraba A, Motoya S, Watanabe K, Nishishita M, Kanke K, Matsui T, Suzuki Y, Oshima T, Kunisaki R, Matsumoto T, Hanai H, Fukunaga K, Yoshimura N, Chiba T, Funakoshi S, Aoyama N, Andoh A, Nakase H, Mizuta Y, Suzuki R, Akamatsu T, Iizuka M, Ashida T, Hibi T.
    Am J Gastroenterol; 2009 Dec; 104(12):2990-5. PubMed ID: 19724269
    [Abstract] [Full Text] [Related]

  • 5. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T, Okanobu H, Yoshimi S, Murakami E, Kogame A, Imagawa H, Numata Y, Kuga Y, Moriya T, Ohya T, Kajiyama G.
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [Abstract] [Full Text] [Related]

  • 6. The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.
    Passalacqua S, Ferraro PM, Bresci G, D'Ovidio V, Astegiano M, Principi M, Testa R, D'Incà R, Valpiani D, Armuzzi A, Sablich R, Cavallaro F, Costa F, Di Leo V, Colombo E, Santini A, Aratari A, Lecis P, Saladino V, Riegler G, Marco M, Calella F, Ricci C, Guidi ML, Repaci G, Silla M.
    J Clin Apher; 2011 Dec; 26(6):332-7. PubMed ID: 22072543
    [Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
    Sands BE, Sandborn WJ, Feagan B, Löfberg R, Hibi T, Wang T, Gustofson LM, Wong CJ, Vandervoort MK, Hanauer S, Adacolumn Study Group.
    Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921
    [Abstract] [Full Text] [Related]

  • 8. Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.
    Schultheiß C, Weischenberg R, Herrmann A, Haller B, Schmid RM, Reindl W, Huber W.
    Artif Organs; 2015 Feb; 39(2):187-92. PubMed ID: 24981894
    [Abstract] [Full Text] [Related]

  • 9. A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis.
    Sakuraba A, Sato T, Naganuma M, Morohoshi Y, Matsuoka K, Inoue N, Takaishi H, Ogata H, Iwao Y, Hibi T.
    J Gastroenterol; 2008 Feb; 43(1):51-6. PubMed ID: 18297436
    [Abstract] [Full Text] [Related]

  • 10. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study.
    Hanai H, Watanabe F, Takeuchi K, Iida T, Yamada M, Iwaoka Y, Saniabadi A, Matsushita I, Sato Y, Tozawa K, Arai H, Furuta T, Sugimoto K, Bjarnason I.
    Clin Gastroenterol Hepatol; 2003 Jan; 1(1):28-35. PubMed ID: 15017514
    [Abstract] [Full Text] [Related]

  • 11. Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study.
    Yamamoto T, Umegae S, Kitagawa T, Yasuda Y, Yamada Y, Takahashi D, Mukumoto M, Nishimura N, Yasue K, Matsumoto K.
    Aliment Pharmacol Ther; 2004 Oct 01; 20(7):783-92. PubMed ID: 15379839
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis.
    Yamamoto S, Nakase H, Matsuura M, Masuda S, Inui K, Chiba T.
    J Clin Gastroenterol; 2011 Jul 01; 45(6):526-30. PubMed ID: 21336140
    [Abstract] [Full Text] [Related]

  • 13. Relevance of the processed blood volume per granulocyte and monocyte apheresis session to its clinical efficacy in patients with ulcerative colitis.
    Kikuyama R, Fukunaga K, Kawai M, Yokoyama Y, Kamikozuru K, Hida N, Ohda Y, Takeda N, Yoshida K, Iimuro M, Kato K, Kono T, Nogami K, Nagase K, Nakamura S, Takei Y, Miwa H, Matsumoto T.
    Ther Apher Dial; 2011 Aug 01; 15(4):360-6. PubMed ID: 21884470
    [Abstract] [Full Text] [Related]

  • 14. Factors affecting short- and long-term effects of leukocyte removal therapy in active ulcerative colitis.
    Nakano R, Iwakiri R, Ikeda Y, Kishi T, Tsuruoka N, Shimoda R, Sakata Y, Yamaguchi K, Fujimoto K.
    J Gastroenterol Hepatol; 2013 Feb 01; 28(2):303-8. PubMed ID: 23339387
    [Abstract] [Full Text] [Related]

  • 15. Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis.
    Hanai H, Watanabe F, Yamada M, Sato Y, Takeuchi K, Iida T, Tozawa K, Tanaka T, Maruyama Y, Matsushita I, Iwaoka Y, Kikuch K, Saniabadi AR.
    Digestion; 2004 Feb 01; 70(1):36-44. PubMed ID: 15297776
    [Abstract] [Full Text] [Related]

  • 16. Granulocyte and monocyte adsorption apheresis therapy modulates monocyte-derived dendritic cell function in patients with ulcerative colitis.
    Iwakami Y, Sakuraba A, Sato T, Takada Y, Izumiya M, Ichikawa H, Hibi T.
    Ther Apher Dial; 2009 Apr 01; 13(2):138-46. PubMed ID: 19379153
    [Abstract] [Full Text] [Related]

  • 17. Effect of granulocyte and monocyte adsorption apheresis on urinary albumin excretion and plasma endothelin-1 concentration in patients with active ulcerative colitis.
    Nakamura T, Kawagoe Y, Matsuda T, Ueda A, Ueda Y, Takahashi Y, Tanaka A, Koide H.
    Blood Purif; 2004 Apr 01; 22(6):499-504. PubMed ID: 15528877
    [Abstract] [Full Text] [Related]

  • 18. Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis.
    Yamamoto T, Umegae S, Matsumoto K.
    J Crohns Colitis; 2012 Aug 01; 6(7):750-5. PubMed ID: 22398094
    [Abstract] [Full Text] [Related]

  • 19. Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: an unblinded randomised multi-centre controlled study.
    Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Kageoka M, Ikeya K, Yamada M, Kikuyama M, Iwaoka Y, Hirayama K, Nagata S, Sato Y, Hosoda Y.
    Dig Liver Dis; 2008 Jun 01; 40(6):433-40. PubMed ID: 18296130
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
    Sakata Y, Iwakiri R, Amemori S, Yamaguchi K, Fujise T, Otani H, Shimoda R, Tsunada S, Sakata H, Ikeda Y, Ando T, Nakafusa Y, Fujimoto K.
    Eur J Gastroenterol Hepatol; 2008 Jul 01; 20(7):629-33. PubMed ID: 18679064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.